These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5970189)

  • 1. Elevation of the concentration of plasma oxalic acid in renal failure.
    Zarembski PM; Hodgkinson A; Parsons FM
    Nature; 1966 Oct; 212(5061):511-2. PubMed ID: 5970189
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H
    Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary oxalosis in chronic renal insufficiency].
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis.
    Ahmad S; Hatch M
    Nephron; 1985; 41(3):235-40. PubMed ID: 4058624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated peritoneal dialysis: analysis of several methods of peritoneal dialysis.
    Miller JH; Gipstein R; Margules R; Schwartz M; Rubini ME
    Trans Am Soc Artif Intern Organs; 1966; 12():98-105. PubMed ID: 5960742
    [No Abstract]   [Full Text] [Related]  

  • 6. Removal of urea, creatinine, uric acid and inorganic phosphate by a rotating-drum artificial kidney.
    KENNEDY AC; GRAY MJ; DINWOODIE A; LINTON AL
    Lancet; 1961 Nov; 2(7210):996-8. PubMed ID: 14455151
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oxalic acid metabolism in chronic renal failure].
    Balcke P
    Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution of electrolytes and substances normally contained in urine in the extracellular space under dialysis].
    Klütsch K; Grosswendt J; Scheitza E; Heidland A
    Klin Wochenschr; 1968 Nov; 46(21):1170-1. PubMed ID: 5703461
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum oxalate in chronic renal failure.
    Borland WW; Payton CD; Simpson K; Macdougall AI
    Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary hyperoxalemia in chronic renal failure.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Int J Artif Organs; 1982 May; 5(3):141-3. PubMed ID: 7107047
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperoxalemia and secondary oxalosis of chronic renal insufficiency].
    Schillinger F; Montagnac R; Milcent T
    Nephrologie; 1990; 11(4):211-5. PubMed ID: 2074920
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro synthesis of oxalic acid has no relevant influence on plasma oxalic acid levels in haemodialysis patients.
    Balcke P; Schmidt P; Zazgornik J; Haubenstock A; Kopsa H
    J Clin Chem Clin Biochem; 1984 Mar; 22(3):261-3. PubMed ID: 6726124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of uremic sera on renal tubular P-aminohippurate transport.
    Preuss HG; Massry SG; Maher JF; Gilliece M; Schreiner GE
    Nephron; 1966; 3(5):265-73. PubMed ID: 5965067
    [No Abstract]   [Full Text] [Related]  

  • 14. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Haubenstock A
    Ann Intern Med; 1984 Sep; 101(3):344-5. PubMed ID: 6465702
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labeled insulin catabolism in chronic renal failure and in the anephric state.
    Corvilain J; Brauman H; Delcroix C; Toussaint C; Vereerstraeten P; Franckson JR
    Diabetes; 1971 Jul; 20(7):467-75. PubMed ID: 5556283
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
    Pru C; Eaton J; Kjellstrand C
    Nephron; 1985; 39(2):112-6. PubMed ID: 3974772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal insufficiency and uric acid metabolism: harmful effect of uric acid and new interpretation of uric acid metabolism].
    Suzuki Y; Mimura N
    Nihon Rinsho; 1974 Mar; 32(3):488-95. PubMed ID: 4603800
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary oxalic acid excretion in chronic kidney failure and after kidney transplantation].
    Mydlík M; Derzsiová K; Pribylincová V; Reznícek J
    Vnitr Lek; 1996 Dec; 42(12):813-7. PubMed ID: 9072879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma oxalate in chronic renal failure and normal subjects: methodological problems.
    Dorhout Mees EJ; Boer P
    Nephron; 1988; 48(3):256-7. PubMed ID: 3352859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.